Back

Long QT Syndrome is not a contraindication to competitive sport - PRO

20 March 2018 (09:18 - 09:31)
Organised by:
Congress Presentation Part of: Controversies in channelopathy Long QT Syndrome EHRA Premium Access EHRA 2018

About the speaker

Photo
Doctor Michael Ackerman

Mayo Clinic, Rochester (United States of America)

11 More presentations in this session

Presentation thumbnail
Opening question
Slides Video
Presentation thumbnail
Ablation should be 1st line therapy in the high risk Brugada Syndrome patient - PRO
Professor V. Probst (Nantes, FR)
Slides Video
Presentation thumbnail
Ablation should be 1st line therapy in the high risk Brugada Syndrome patient - CON
Professor S. Viskin (Tel Aviv, IL)
Slides Video
Presentation thumbnail
Ablation should be 1st line therapy in the high risk Brugada Syndrome patient - Rebuttal PRO
Video
Presentation thumbnail
Ablation should be 1st line therapy in the high risk Brugada Syndrome patient - Rebuttal CON
Video

Access the full session

Session thumbnail
Controversies in channelopathy

The Event

Event poster

EHRA 2018

20 March 2018 09:18 CET
You may be interested in
thumbnail
Congress Presentation
Case 2: an athlete with a long QT interval
2 September 2024
thumbnail
Congress Presentation
QRS voltages in the limb leads - findings from a nationwide cardiac screening program in adolescent athletes and non-athletes (BEAT-IT)
3 April 2025
thumbnail
Congress Presentation
The utility of the implantable loop recorder in patients with a diagnosis or family history of long QT syndrome
27 August 2021
thumbnail
Practice Tools
A 15-year-old competitive athlete with asymptomatic polymorphic wide QRS arrhythmias
18 September 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources